188 related articles for article (PubMed ID: 1848524)
1. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer].
Isobe H
Hokkaido Igaku Zasshi; 1991 Jan; 66(1):49-58. PubMed ID: 1848524
[TBL] [Abstract][Full Text] [Related]
2. [Flow cytometric analysis of the DNA content of resected non-small cell lung cancer with reference to long-term follow-up].
Nagai S; Chiba W; Ikeda S; Matsumoto H; Fujimoto T; Ishida H; Wazawa H; Hanawa T; Yamashita N; Yasuda Y; Matsubara Y; Hatakenaka R; Funatsu T
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():130-4. PubMed ID: 8678555
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
[TBL] [Abstract][Full Text] [Related]
4. [The prognostic significance of nuclear DNA content in non-small-cell lung carcinoma].
Yamaoka N; Uchiyama Y; Kimino K; Akamine S; Matsuo S; Tsuji K
Nihon Geka Gakkai Zasshi; 1990 Oct; 91(10):1608-16. PubMed ID: 2175839
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric DNA content and clinical outcome in patients with non-small cell lung cancer given postoperative radiation therapy.
Yu J; Shaeffer J; Zhu A; Kuban DA; el-Mahdi AM; Philput CB
Cytometry; 1993; 14(4):428-32. PubMed ID: 8390343
[TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma.
Volm M; Hahn EW; Mattern J; Müller T; Vogt-Moykopf I; Weber E
Cancer Res; 1988 May; 48(10):2923-8. PubMed ID: 2834052
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
Mørkve O; Halvorsen OJ; Skjaerven R; Stangeland L; Gulsvik A; Laerum OD
Anticancer Res; 1993; 13(3):571-8. PubMed ID: 8391242
[TBL] [Abstract][Full Text] [Related]
8. In situ evaluation of growth fraction determined by monoclonal antibody Ki-67 and ploidy in surgically resected non-small cell lung cancers.
Simony J; Pujol JL; Radal M; Ursule E; Michel FB; Pujol H
Cancer Res; 1990 Jul; 50(14):4382-7. PubMed ID: 2163748
[TBL] [Abstract][Full Text] [Related]
9. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
Ljungberg B
Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of flow cytometry in non-small-cell lung cancer.
Rice TW; Bauer TW; Gephardt GN; Medendorp SV; McLain DA; Kirby TJ
J Thorac Cardiovasc Surg; 1993 Aug; 106(2):210-7. PubMed ID: 8393505
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytometric analysis of cellular DNA content of lung cancer with reference to survival].
Shiota T; Konishi T; Kosaba S; Mitsuoka A; Matsubara Y; Hatakenaka R; Funatsu T; Ikeda S; Matsumoto H; Ishigami F
Nihon Kyobu Geka Gakkai Zasshi; 1990 Dec; 38(12):2364-9. PubMed ID: 2290045
[TBL] [Abstract][Full Text] [Related]
13. [Flow cytometric analysis in non-small-cell bronchial carcinoma and its prognostic significance].
Liewald F; Sunder-Plassmann L; Valet G; Wulf G; Weiss M; Schildberg FW
Chirurg; 1992 Mar; 63(3):205-10. PubMed ID: 1313755
[TBL] [Abstract][Full Text] [Related]
14. [DNA content and its correlation with biological behavior of non-small cell lung cancer].
Hu YP; He LX; Yu D; Xia HS; Ke YH; Yang L; Jiang H; Xiao ZH; Fu XY; Fan YH
Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):55-8. PubMed ID: 12678989
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic value of flow cytometry in squamous cell bronchogenic cancer. A retrospective study of 61 cases].
Jeanfaivre T; Chassevent A; Geslin J; Larra F; Tuchais E
Bull Cancer; 1997 Jun; 84(6):597-602. PubMed ID: 9295862
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung.
Carey FA; Prasad US; Walker WS; Cameron EW; Lamb D; Bird CC
J Thorac Cardiovasc Surg; 1992 Jun; 103(6):1214-7. PubMed ID: 1317930
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data.
Choma D; Daurès JP; Quantin X; Pujol JL
Br J Cancer; 2001 Jul; 85(1):14-22. PubMed ID: 11437396
[TBL] [Abstract][Full Text] [Related]
18. DNA content and its relationship with pathology and prognosis of colorectal carcinoma.
Jiang B; Liu CG; Wang MW; Zhao DH; Li Y; Ji XL
Chin Med J (Engl); 1992 Mar; 105(3):241-6. PubMed ID: 1395845
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric nuclear DNA content of fresh and paraffin-embedded tissues of breast carcinomas and fibroadenomas.
De Vita R; Calugi A; Eleuteri P; Maggi O; Nassuato C; Vecchione A
Eur J Basic Appl Histochem; 1991; 35(3):233-44. PubMed ID: 1718443
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
Volm M; Drings P; Kleine W; Mattern J
Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
